UnknownPhase 3

Transcranial Magnetic Stimulation (TMS) for Patients With Treatment Resistant Auditory Verbal Hallucination

Indonesia40 participantsStarted 2018-02-01

Plain-language summary

This study will evaluate the effect of repetitive transcranial magnetic stimulation (rTMS) in schizophrenia with treatment resistant auditory verbal hallucination

Who can participate

Age range18 Years – 59 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Met the criteria of all types of schizophrenia or schizoaffective based on structured clinical interview instruments for the DSM-IV axis I disorders (SCID-I)
✓. Patients had entered the stabilization phase with 2 to 3 months of antipsychotic treatment and no drug changes within the last 2 (two) months
✓. Elementary school graduated (minimum)

Exclusion criteria

✕. Patients with a history of stroke, heart failure, head injury, infection or brain tumor, epilepsy, alcohol and opiate abuse, amphetamines obtained from anamnesis, physical examination and patient medical records
✕. Patients with neurological focal deficits such as hemiparesis and cranial nerve paresis
✕. Patients with severe cognitive deficits (MMSE scores \<25 in the first and second graders of Senior Secondary School and \<21 in Primary School Graduates)
✕. Patients with severe hearing loss were assessed with a 5-word auditory test
✕. Patients with mental retardation, assessed using the Wechsler Test of Adult Reading (WTAR) test and data from medical records.

What they're measuring

Hallucinations change

Timeframe: 2 weeks

Source-monitoring ability

Timeframe: 2 weeks

Trial details

NCT IDNCT03762746

SponsorDr Cipto Mangunkusumo General Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2018-12-01

Contact for this trial

Khamelia Malik, MD

+6181281296600 khameliapsi@gmail.com

View on ClinicalTrials.gov More Hallucinations, Verbal Auditory trials